8-K Announcements
6Material company update
Apr 10, 2026·SEC
Material company update
Mar 11, 2026·SEC
Material company update
Feb 27, 2026·SEC
Healthcare Triangle, Inc.(HCTI)Earnings, Financials & Key Ratios
HCTI•NASDAQ
$2.38
$50449 mkt cap·Price updated May 6, 2026
AboutHealthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and enhance the digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure across private, hybrid, and public cloud infrastructures; and DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, it offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery on public cloud. The company primarily serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. Healthcare Triangle, Inc. was incorporated in 2019 and is based in Pleasanton, California. Healthcare Triangle, Inc. operates as a subsidiary of SecureKloud Technologies, Inc.Show more
- Revenue$12M-64.8%
- EBITDA-$4M+6.2%
- Net Income-$6M+51.6%
- EPS (Diluted)-281.58+45.6%
- Gross Margin24.71%+21.1%
- EBITDA Margin-33.02%-166.4%
- Operating Margin-40.62%-18.9%
- Net Margin-51.03%-37.3%
- ROIC-626.78%-528.9%
- Interest Coverage-3.92+66.6%
HCTI Key Insights
Healthcare Triangle, Inc. (HCTI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Efficient asset utilization: 6.0x turnover
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 1 (bottom 1%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Sales declining 16.5% over 5 years
- ✗Shares diluted 26.3% in last year
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
HCTI Price & Volume
Healthcare Triangle, Inc. (HCTI) stock price & volume — 10-year historical chart
Loading chart...
HCTI Growth Metrics
Healthcare Triangle, Inc. (HCTI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-16.46%
3 Years-30.78%
TTM-21.88%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM36.48%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM45.36%
Return on Capital
10 Years-126.04%
5 Years-167.51%
3 Years-275.72%
Last Year-626.78%
HCTI Peer Comparison
Healthcare Triangle, Inc. (HCTI) competitors in Healthcare Data, Analytics and AI — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HIMS | 6.94B | 26.88 | 52.71 | 59% | 5.47% | 23.73% | 2.07 | |
 HCAT | 111.47M | 1.57 | -0.62 | 1.48% | -57.2% | -54.67% | 0.08 | |
 MTEX | 9.28M | 4.88 | 3.70 | -10.68% | -1.5% | -23.83% | 0.78 | |
 VEEV | 27.2B | 167.29 | 30.75 | 16.34% | 28.44% | 13.41% | 0.01 | |
 INVA | 1.91B | 22.52 | 6.82 | 18.52% | 118.91% | 46.47% | 0.23 | |
 DOCS | 5.17B | 25.69 | 23.14 | 19.98% | 37.54% | 24.45% | 0.01 | |
 MSFT | 3.07T | 413.87 | 30.34 | 14.93% | 39.34% | 33.13% | 0.33 | |
 AMZN | 2.96T | 274.95 | 38.35 | 12.38% | 12.22% | 23.34% | 0.37 |
Compare HCTI vs Peers
Healthcare Triangle, Inc. (HCTI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HCTI Income Statement
Healthcare Triangle, Inc. (HCTI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 28.74M | 31.34M | 35.27M | 45.89M | 33.2M | 11.7M | 12.94M |
| Revenue Growth % | - | 9.06% | 12.54% | 30.1% | -27.64% | -64.77% | -21.88% |
| Cost of Goods Sold | 22.89M | 22.75M | 24.75M | 34.59M | 26.43M | 8.81M | 11.24M |
| COGS % of Revenue | 79.65% | 72.6% | 70.17% | 75.38% | 79.59% | 75.29% | - |
| Gross Profit | 5.85M▲ 0% | 8.59M▲ 46.8% | 10.52M▲ 22.5% | 11.29M▲ 7.4% | 6.78M▼ 40.0% | 2.89M▼ 57.4% | 1.7M▲ 0% |
| Gross Margin % | 20.35% | 27.4% | 29.83% | 24.62% | 20.41% | 24.71% | 13.11% |
| Gross Profit Growth % | - | 46.8% | 22.54% | 7.35% | -40% | -57.36% | - |
| Operating Expenses | 4.18M | 7.41M | 15.88M | 21.71M | 18.13M | 7.64M | 7.54M |
| OpEx % of Revenue | 14.54% | 23.64% | 45.03% | 47.31% | 54.59% | 65.33% | - |
| Selling, General & Admin | 2.39M | 4.86M | 9.2M | 12.38M | 10.09M | 6.15M | 5.62M |
| SG&A % of Revenue | 8.32% | 15.52% | 26.09% | 26.99% | 30.4% | 52.61% | - |
| Research & Development | 1.01M | 1.74M | 5.26M | 5.95M | 799K | 429K | 178K |
| R&D % of Revenue | 3.53% | 5.56% | 14.91% | 12.97% | 2.41% | 3.67% | - |
| Other Operating Expenses | 776.13K | 803.19K | 1.42M | 3.37M | 7.23M | 1.06M | 658K |
| Operating Income | 1.67M▲ 0% | 1.18M▼ 29.5% | -5.36M▼ 555.4% | -10.42M▼ 94.4% | -11.35M▼ 8.9% | -4.75M▲ 58.1% | -5.85M▲ 0% |
| Operating Margin % | 5.81% | 3.75% | -15.19% | -22.7% | -34.18% | -40.62% | -45.17% |
| Operating Income Growth % | - | -29.5% | -555.43% | -94.36% | -8.95% | 58.13% | - |
| EBITDA | 2.45M | 1.98M | -3.94M | -7.04M | -4.12M | -3.86M | -5.92M |
| EBITDA Margin % | 8.51% | 6.32% | -11.16% | -15.35% | -12.4% | -33.02% | -45.71% |
| EBITDA Growth % | - | -19.03% | -298.87% | -78.85% | 41.55% | 6.17% | -96.15% |
| D&A (Non-Cash Add-back) | 776.13K | 803.19K | 1.42M | 3.37M | 7.23M | 889K | -69.8K |
| EBIT | 1.67M | 1.18M | -5.36M | -9.34M | -11.34M | -4.74M | -5M |
| Net Interest Income | -52.58K | -78.65K | -567K | -212K | -968K | -1.21M | -1.32M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 52.58K | 78.65K | 567K | 212K | 968K | 1.21M | 1.32M |
| Other Income/Expense | -52.58K | 1.43M | -565.95K | 869K | -956K | -1.21M | -472K |
| Pretax Income | 1.62M▲ 0% | 2.61M▲ 61.5% | -5.92M▼ 326.9% | -9.55M▼ 61.1% | -12.3M▼ 28.9% | -5.96M▲ 51.6% | -6.32M▲ 0% |
| Pretax Margin % | 5.63% | 8.33% | -16.8% | -20.81% | -37.06% | -50.93% | -48.82% |
| Income Tax | 444.37K | 257.38K | 24K | 63K | 35K | 12K | 4K |
| Effective Tax Rate % | 27.49% | 9.86% | -0.41% | -0.66% | -0.28% | -0.2% | -0.06% |
| Net Income | 1.17M▲ 0% | 2.35M▲ 100.8% | -5.95M▼ 352.8% | -9.61M▼ 61.5% | -12.34M▼ 28.4% | -5.97M▲ 51.6% | -6.32M▲ 0% |
| Net Margin % | 4.08% | 7.51% | -16.87% | -20.94% | -37.16% | -51.03% | -48.85% |
| Net Income Growth % | - | 100.79% | -352.82% | -61.51% | -28.4% | 51.62% | 36.48% |
| Net Income (Continuing) | 1.17M | 2.35M | -5.95M | -9.61M | -12.34M | -5.97M | -6.32M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -18K |
| EPS (Diluted) | 82.94▲ 0% | 166.56▲ 100.8% | -503.45▼ 402.3% | -966.64▼ 92.0% | -517.53▲ 46.5% | -281.58▲ 45.6% | -298.25▲ 0% |
| EPS Growth % | - | 100.81% | -402.27% | -92% | 46.46% | 45.59% | 45.36% |
| EPS (Basic) | 82.94 | 166.56 | -503.45 | -966.64 | -517.53 | -281.58 | - |
| Diluted Shares Outstanding | 14.13K | 14.13K | 11.82K | 14.85K | 16.78K | 21.2K | 21.2K |
| Basic Shares Outstanding | 14.13K | 14.13K | 11.82K | 14.85K | 16.78K | 21.2K | 21.2K |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
HCTI Balance Sheet
Healthcare Triangle, Inc. (HCTI) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 5.29M | 8.03M | 11.8M | 7.75M | 5.73M | 1.45M | 7.94M |
| Cash & Short-Term Investments | 974.83K | 1.4M | 1.77M | 1.34M | 1.23M | 20K | 1.63M |
| Cash Only | 974.83K | 1.4M | 1.77M | 1.34M | 1.23M | 20K | 1.63M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 4.17M | 6.4M | 9.67M | 5.59M | 3.24M | 1.11M | 5.94M |
| Days Sales Outstanding | 52.97 | 74.5 | 100.1 | 44.48 | 35.57 | 34.64 | 99.72 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - |
| Other Current Assets | 146.3K | 228.85K | 361.48K | 816K | 1.26M | 322K | 284K |
| Total Non-Current Assets | 2.96M | 3.08M | 12.81M | 13.01M | 4.32M | 509K | 5.9M |
| Property, Plant & Equipment | 41.65K | 15.79K | 246.32K | 80K | 44K | 12K | 5K |
| Fixed Asset Turnover | 690.02x | 1985.24x | 143.19x | 573.58x | 754.61x | 974.67x | 2588.20x |
| Goodwill | 0 | 0 | 1.29M | 1.29M | 0 | 0 | 0 |
| Intangible Assets | 2.92M | 2.62M | 10.46M | 10.57M | 3.97M | 0 | 5.89M |
| Long-Term Investments | 0 | 445K | 816.24K | 1.07M | 304K | 497K | 2.44M |
| Other Non-Current Assets | 0 | 445K | 816.24K | 1.07M | 0 | 0 | 0 |
| Total Assets | 8.25M▲ 0% | 11.11M▲ 34.6% | 24.61M▲ 121.6% | 20.76M▼ 15.6% | 10.05M▼ 51.6% | 1.96M▼ 80.5% | 13.84M▲ 0% |
| Asset Turnover | 3.48x | 2.82x | 1.43x | 2.21x | 3.30x | 5.96x | 1.23x |
| Asset Growth % | - | 34.6% | 121.58% | -15.64% | -51.6% | -80.49% | 323.31% |
| Total Current Liabilities | 6.2M | 6.78M | 6.25M | 6.15M | 8.12M | 7.08M | 3.91M |
| Accounts Payable | 5.1M | 4.35M | 1.87M | 1.48M | 1.95M | 2.54M | 1.31M |
| Days Payables Outstanding | 81.33 | 69.78 | 27.62 | 15.63 | 26.98 | 105.24 | 61.18 |
| Short-Term Debt | 0 | 754.4K | 3.28M | 2.41M | 3.43M | 2.65M | 1.53M |
| Deferred Revenue (Current) | 749.03K | 297.77K | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 349.14K | 1.38M | 923.88K | 2.25M | 2.74M | 1.89M | 1.07M |
| Current Ratio | 0.85x | 1.18x | 1.89x | 1.26x | 0.71x | 0.21x | 0.21x |
| Quick Ratio | 0.85x | 1.18x | 1.89x | 1.26x | 0.71x | 0.21x | 0.21x |
| Cash Conversion Cycle | - | - | - | - | - | - | 38.54 |
| Total Non-Current Liabilities | 79.04K | 0 | 2.23M | 2.23M | 1.39M | 0 | 1.2M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 888K | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 79.04K | 0 | 2.23M | 2.23M | 500K | 0 | 2.4M |
| Total Liabilities | 6.28M | 6.78M | 8.48M | 8.38M | 9.51M | 7.08M | 5.11M |
| Total Debt | 0 | 754.4K | 3.45M | 2.41M | 4.32M | 2.65M | 1.53M |
| Net Debt | -974.83K | -648.3K | 1.68M | 1.07M | 3.08M | 2.63M | -99K |
| Debt / Equity | - | 0.17x | 0.21x | 0.19x | 8.02x | - | 0.18x |
| Debt / EBITDA | - | 0.38x | - | - | - | - | -0.26x |
| Net Debt / EBITDA | -0.40x | -0.33x | - | - | - | - | 0.02x |
| Interest Coverage | 31.75x | 14.96x | -9.45x | -49.13x | -11.72x | -3.92x | -3.79x |
| Total Equity | 1.97M▲ 0% | 4.33M▲ 119.2% | 16.13M▲ 272.8% | 12.39M▼ 23.2% | 538K▼ 95.7% | -5.11M▼ 1050.6% | 8.73M▲ 0% |
| Equity Growth % | - | 119.17% | 272.77% | -23.22% | -95.66% | -1050.56% | 2988.23% |
| Book Value per Share | 139.77 | 306.32 | 1365.28 | 834.04 | 32.06 | -241.26 | 411.66 |
| Total Shareholders' Equity | 1.97M | 4.33M | 16.13M | 12.39M | 538K | -5.11M | 8.74M |
| Common Stock | 279 | 279 | 353 | 0 | 0 | 0 | 11K |
| Retained Earnings | 932.63K | 3.29M | -2.66M | -12.57M | -24.91M | -33.57M | -38.52M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 3M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -18K |
HCTI Cash Flow Statement
Healthcare Triangle, Inc. (HCTI) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|
| Cash from Operations | 3.97M | -734.67K | -7.11M | -2.6M | -1.61M | -1.08M | -1.08M |
| Operating CF Margin % | 13.81% | -2.34% | -20.16% | -5.67% | -4.86% | -9.24% | - |
| Operating CF Growth % | - | -118.52% | -868.05% | 63.44% | 38% | 32.94% | -11737.31% |
| Net Income | 1.17M | 2.35M | -5.95M | -9.61M | -12.34M | -5.97M | -6.32M |
| Depreciation & Amortization | 776.13K | 803.19K | 1.42M | 3.37M | 7.23M | 889K | -69.8K |
| Stock-Based Compensation | 0 | 0 | 52K | 257K | 17K | 87K | 17K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.29M | 0 | 1.31M | -928K | 481K | 1.22M | 949.8K |
| Working Capital Changes | -1.27M | -3.89M | -3.95M | 4.31M | 3M | 2.69M | -5.54M |
| Change in Receivables | 212.99K | -2.23M | -3.65M | 4.08M | 2.27M | 2.12M | -2.01M |
| Change in Inventory | -3.42M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 3.42M | -750.38K | 0 | -392K | 484K | 0 | -309K |
| Cash from Investing | -3.65M | -477.46K | -7.63M | -3.32M | -13K | 0 | -1.29M |
| Capital Expenditures | -3.65M | -477.46K | -3.13M | -3.32M | -13K | 0 | -1.29M |
| CapEx % of Revenue | 12.7% | 1.52% | 8.87% | 7.23% | 0.04% | - | - |
| Acquisitions | 0 | 0 | -4.5M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 1.64M | 15.11M | 5.49M | 1.52M | -133K | 13.86M |
| Debt Issued (Net) | 0 | 1.64M | 888K | 9K | 1.02M | -1.09M | 508K |
| Equity Issued (Net) | 0 | 0 | 1000K | 1000K | 500K | 0 | 672K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -142K | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | -265K | 0 | 956K | 0 |
| Net Change in Cash | 318.86K▲ 0% | 427.87K▲ 34.2% | 367K▼ 14.2% | -429K▼ 216.9% | -107K▲ 75.1% | -1.21M▼ 1034.6% | 1.6M▲ 0% |
| Free Cash Flow | 318.86K▲ 0% | -734.67K▼ 330.4% | -10.24M▼ 1294.0% | -5.92M▲ 42.2% | -1.63M▲ 72.5% | -1.08M▲ 33.5% | -12.26M▲ 0% |
| FCF Margin % | 1.11% | -2.34% | -29.04% | -12.9% | -4.89% | -9.24% | -94.71% |
| FCF Growth % | - | -330.4% | -1293.96% | 42.2% | 72.55% | 33.48% | -1406.61% |
| FCF per Share | 22.57 | -51.99 | -866.56 | -398.51 | -96.82 | -51.00 | -51.00 |
| FCF Conversion (FCF/Net Income) | 3.39x | -0.31x | 1.20x | 0.27x | 0.13x | 0.18x | 1.94x |
| Interest Paid | 0 | 0 | 567K | 212K | 968K | 121K | 174K |
| Taxes Paid | 0 | 0 | 24K | 357K | 35K | 12K | -8K |
HCTI Key Ratios
Healthcare Triangle, Inc. (HCTI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 74.67% | -58.15% | -67.38% | -190.92% | - | -112.9% |
| Return on Invested Capital (ROIC) | 37.71% | -37.39% | -49.95% | -99.66% | -626.78% | -626.78% |
| Gross Margin | 27.4% | 29.83% | 24.62% | 20.41% | 24.71% | 13.11% |
| Net Margin | 7.51% | -16.87% | -20.94% | -37.16% | -51.03% | -48.85% |
| Debt / Equity | 0.17x | 0.21x | 0.19x | 8.02x | - | 0.18x |
| Interest Coverage | 14.96x | -9.45x | -49.13x | -11.72x | -3.92x | -3.79x |
| FCF Conversion | -0.31x | 1.20x | 0.27x | 0.13x | 0.18x | 1.94x |
| Revenue Growth | 9.06% | 12.54% | 30.1% | -27.64% | -64.77% | -21.88% |
HCTI SEC Filings & Documents
Healthcare Triangle, Inc. (HCTI) SEC filings — annual & quarterly reports (10-K, 10-Q)
HCTI Frequently Asked Questions
Healthcare Triangle, Inc. (HCTI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Healthcare Triangle, Inc. (HCTI) reported $12.9M in revenue for fiscal year 2024. This represents a 55% decrease from $28.7M in 2019.
Healthcare Triangle, Inc. (HCTI) saw revenue decline by 64.8% over the past year.
Healthcare Triangle, Inc. (HCTI) reported a net loss of $6.3M for fiscal year 2024.
Dividend & Returns
Healthcare Triangle, Inc. (HCTI) had negative free cash flow of $12.3M in fiscal year 2024, likely due to heavy capital investments.
Explore More HCTI
Healthcare Triangle, Inc. (HCTI) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates